LYTIR

Insider · SEC Form 4 · Chief Executive Officer

Andrew Toy

Filed with the SEC as Toy Andrew; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: sold $4.0M of CLOV. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $4.0M in total.Jul: Insider sales $2.0MAug: Insider sales $408KOct: Insider sales $1.6MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $4.0M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. CLOVSold: CLOVER HEALTH INVESTMENTS, CORP. /DE Oct 15, 2026 62,176 shares filed Oct 19, 2026 9,078,334 shares held directly after, as filed 10b5-1 plan filing $291K
  2. CLOVSold: CLOVER HEALTH INVESTMENTS, CORP. /DE Oct 1, 2026 318,806 shares filed Oct 2, 2026 9,140,510 shares held directly after, as filed 10b5-1 plan filing $1.3M
  3. CLOVSold: CLOVER HEALTH INVESTMENTS, CORP. /DE Aug 10, 2026 87,798 shares filed Aug 10, 2026 9,459,316 shares held directly after, as filed 10b5-1 plan filing $408K
  4. CLOVSold: CLOVER HEALTH INVESTMENTS, CORP. /DE Jul 15, 2026 62,711 shares filed Jul 16, 2026 9,547,114 shares held directly after, as filed 10b5-1 plan filing $293K
  5. CLOVSold: CLOVER HEALTH INVESTMENTS, CORP. /DE Jul 1, 2026 313,476 shares filed Jul 1, 2026 9,609,825 shares held directly after, as filed 10b5-1 plan filing $1.7M

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.